expressions Search Results


94
Sino Biological human mpeg1 expression plasmid
Human Mpeg1 Expression Plasmid, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pm41961488-272-1-10?v=Sino+Biological
Average 94 stars, based on 1 article reviews
human mpeg1 expression plasmid - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

95
New England Biolabs shuffle t7 express lysy competent escherichia coli
Shuffle T7 Express Lysy Competent Escherichia Coli, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pm42091878-256-18-25?v=New+England+Biolabs
Average 95 stars, based on 1 article reviews
shuffle t7 express lysy competent escherichia coli - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

86
10X Genomics single cell
Single Cell, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pmc10966806-331-19-17?v=10X+Genomics
Average 86 stars, based on 1 article reviews
single cell - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics csf1r expression
Figure 1. Sex-dependent differences in microglia density and morphology under <t>CSF1R</t> inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.
Csf1r Expression, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pm39842435-111-24-27?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
csf1r expression - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Jackson Laboratory ovalbumin
Figure 1. Sex-dependent differences in microglia density and morphology under <t>CSF1R</t> inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.
Ovalbumin, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pm38091950-241-164-177?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
ovalbumin - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

94
Novus Biologicals anti tex264
Figure 1. Sex-dependent differences in microglia density and morphology under <t>CSF1R</t> inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.
Anti Tex264, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pmc11937434-413-7-21?v=Novus+Biologicals
Average 94 stars, based on 1 article reviews
anti tex264 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

94
Danaher Inc primetime gene expression master mix 2x
Figure 1. Sex-dependent differences in microglia density and morphology under <t>CSF1R</t> inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.
Primetime Gene Expression Master Mix 2x, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pmc07658358-213-7-13?v=Danaher+Inc
Average 94 stars, based on 1 article reviews
primetime gene expression master mix 2x - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

99
Expression Systems Inc sf9 cells
Figure 1. Sex-dependent differences in microglia density and morphology under <t>CSF1R</t> inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.
Sf9 Cells, supplied by Expression Systems Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/us12583886-471-2-10?v=Expression+Systems+Inc
Average 99 stars, based on 1 article reviews
sf9 cells - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

93
R&D Systems rh rankl
Figure 1. Sex-dependent differences in microglia density and morphology under <t>CSF1R</t> inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.
Rh Rankl, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pm32145090-84-17-19?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
rh rankl - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

95
R&D Systems sandwich human tgf β1 immunoassay
Figure 1. Sex-dependent differences in microglia density and morphology under <t>CSF1R</t> inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.
Sandwich Human Tgf β1 Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pmc06613042-409-6-11?v=R%26D+Systems
Average 95 stars, based on 1 article reviews
sandwich human tgf β1 immunoassay - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

92
R&D Systems cd40l
FIGURE 9 | IL-21 rescued <t>CD40L</t> and anti-IgM induced cell death in human primary B cells. (A) Representative graphs of CFSE labelling cells showed no differentiation was induced by any stimulatory factors in 3 days. (B) Representative graphs showed that IL-21 could suppress cell death induced by CD40L and anti- IgM in terms of increased number of DAPI- cells. (C) Representative graphs showed that IL-21 was able to induce CD38+ B cell differentiation both in the absence and presence of CD40L.
Cd40l, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pm35911775-93-25-27?v=R%26D+Systems
Average 92 stars, based on 1 article reviews
cd40l - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

94
R&D Systems bmp4
FIGURE 9 | IL-21 rescued <t>CD40L</t> and anti-IgM induced cell death in human primary B cells. (A) Representative graphs of CFSE labelling cells showed no differentiation was induced by any stimulatory factors in 3 days. (B) Representative graphs showed that IL-21 could suppress cell death induced by CD40L and anti- IgM in terms of increased number of DAPI- cells. (C) Representative graphs showed that IL-21 was able to induce CD38+ B cell differentiation both in the absence and presence of CD40L.
Bmp4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expressions/pm36524236-42-22-23?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
bmp4 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

Image Search Results


Figure 1. Sex-dependent differences in microglia density and morphology under CSF1R inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.

Journal: Cell reports

Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice.

doi: 10.1016/j.celrep.2024.115176

Figure Lengend Snippet: Figure 1. Sex-dependent differences in microglia density and morphology under CSF1R inhibition (A) Representative 103 epifluorescence images (cropped from a stitched image representing the whole brain section) showing microglia immunolabeled with Iba1 in hippocampal CA1, white matter (WM), and primary visual cortex V1 in control and PLX-treated male and female mice. (B) Quantification of depletion efficacies across different brain regions as depletion/control microglia density ratios. Briefly, all control animals of each sex were averaged, and the depletion/control ratios were calculated as each PLX animal divided by the control animal average of the same sex. (C) Microglial soma size was unaltered after PLX treatment. (D) Representative 203 confocal image of microglia in V1. Outline shows how individual microglia were cropped out of the image for analysis. (E) Representative image of a thresholded microglia with overlaid concentric circles for Sholl analysis. (F–I)QuantificationofmicroglialramificationastotalShollintersectionsdependingontreatmentandsexinV1(F);CA1,includingSO,SP,andSR(G);SLM(H);andWM(I). n = 6–7 mice/sex/treatment (B and C), n = 3–5 mice/sex/treatment (F–I); two-way ANOVA with Bonferroni correction, *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars: 200 mm. All data are expressed as the mean ± SEM. See also Figures S1–S3.

Article Snippet: After PLX treatment, CSF1R expression decreased in both Galectin-3+ and Galectin-3 microglia in both sexes (Figures 5H and 5I), and Galectin-3+ microglia had higher CSF1R expression than Galectin-3 microglia in males (Figure 5I), while expression normalized between the two populations in females (Figure 5H).

Techniques: Inhibition, Immunolabeling, Control

Figure 3. Sex-dependent differences in microglial transcriptomic landscape during CSF1R inhibition (A) Volcano plot showing DEGs between female and male microglia in control animals. (B) Enrichment analysis revealed upregulation of immune-related pathways in control male microglia compared to female. The small number of upregulated DEGs in females compared to males precluded an enrichment analysis. (C) Volcano plot showing DEGs between female and male microglia after 7 days of PLX treatment. (D) After PLX treatment, upregulated DEGs in females were enriched in pathways related to autophagy and protein homeostasis. (E) After PLX treatment, upregulated DEGs in males were enriched in mitochondrial oxidative phosphorylation and mitotic processes. n = 4 mice/sex/treatment; adjusted p cutoff <0.05. See also Figures S4–S6 and Tables S2 and S5.

Journal: Cell reports

Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice.

doi: 10.1016/j.celrep.2024.115176

Figure Lengend Snippet: Figure 3. Sex-dependent differences in microglial transcriptomic landscape during CSF1R inhibition (A) Volcano plot showing DEGs between female and male microglia in control animals. (B) Enrichment analysis revealed upregulation of immune-related pathways in control male microglia compared to female. The small number of upregulated DEGs in females compared to males precluded an enrichment analysis. (C) Volcano plot showing DEGs between female and male microglia after 7 days of PLX treatment. (D) After PLX treatment, upregulated DEGs in females were enriched in pathways related to autophagy and protein homeostasis. (E) After PLX treatment, upregulated DEGs in males were enriched in mitochondrial oxidative phosphorylation and mitotic processes. n = 4 mice/sex/treatment; adjusted p cutoff <0.05. See also Figures S4–S6 and Tables S2 and S5.

Article Snippet: After PLX treatment, CSF1R expression decreased in both Galectin-3+ and Galectin-3 microglia in both sexes (Figures 5H and 5I), and Galectin-3+ microglia had higher CSF1R expression than Galectin-3 microglia in males (Figure 5I), while expression normalized between the two populations in females (Figure 5H).

Techniques: Inhibition, Control, Phospho-proteomics

Figure 4. Sex-dependent differences in microglial Galectin-3 expression at baseline and under CSF1R inhibition (A and B) Representative 203 confocal images showing microglia immunolabeled with Iba1 (green) and Galectin-3 (magenta) in control (A) and PLX-treated mice (B). For ease of visualization, representative images were subjected to altered brightness/contrast that masks the different Galectin-3 fluorescence intensity. (C) The percentage of Galectin-3+ microglia was higher in females compared to males in both cortex (left) and hippocampus (right), although the effect did not reach statistical significance. (D and E) PLX treatment increased the proportion (D) and density (E) of Galectin-3+ microglia in both males and females, also increasing the level of expression in individual microglia. n = 6–8 mice/sex/treatment (C), n = 3–8 mice/sex/dose (D and E), Student’s t test (C), two-way ANOVA with Bonferroni correction (D and E), p values are reported in Tables S4 and S5. Scale bar: 200 mm. All data are expressed as the mean ± SEM. See also Figure S6.

Journal: Cell reports

Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice.

doi: 10.1016/j.celrep.2024.115176

Figure Lengend Snippet: Figure 4. Sex-dependent differences in microglial Galectin-3 expression at baseline and under CSF1R inhibition (A and B) Representative 203 confocal images showing microglia immunolabeled with Iba1 (green) and Galectin-3 (magenta) in control (A) and PLX-treated mice (B). For ease of visualization, representative images were subjected to altered brightness/contrast that masks the different Galectin-3 fluorescence intensity. (C) The percentage of Galectin-3+ microglia was higher in females compared to males in both cortex (left) and hippocampus (right), although the effect did not reach statistical significance. (D and E) PLX treatment increased the proportion (D) and density (E) of Galectin-3+ microglia in both males and females, also increasing the level of expression in individual microglia. n = 6–8 mice/sex/treatment (C), n = 3–8 mice/sex/dose (D and E), Student’s t test (C), two-way ANOVA with Bonferroni correction (D and E), p values are reported in Tables S4 and S5. Scale bar: 200 mm. All data are expressed as the mean ± SEM. See also Figure S6.

Article Snippet: After PLX treatment, CSF1R expression decreased in both Galectin-3+ and Galectin-3 microglia in both sexes (Figures 5H and 5I), and Galectin-3+ microglia had higher CSF1R expression than Galectin-3 microglia in males (Figure 5I), while expression normalized between the two populations in females (Figure 5H).

Techniques: Expressing, Inhibition, Immunolabeling, Control

Figure 5. Expression patterns of Galectin-3+ microglia at baseline and under CSF1R inhibition (A) Experimental paradigm depicting duration of PLX treatment and subsequent microglia gating and analysis. (B) PLX treatment increases the proportion of microglia expressing Galectin-3 to a greater extent in males compared to females. (C) PLX treatment increases the expression levels of Galectin-3 in Galectin-3+ microglia to a greater extent in males compared to females. (D–F) PLX treatment led to increased mitochondrial mass in female and male microglia, as estimated by expression of MitoTracker green. This effect was larger in males than in females (D). In both control and PLX groups, Galectin-3+ microglia appear to have a higher mitochondrial mass compared to Galectin-3 microglia in females (E) and males (F).

Journal: Cell reports

Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice.

doi: 10.1016/j.celrep.2024.115176

Figure Lengend Snippet: Figure 5. Expression patterns of Galectin-3+ microglia at baseline and under CSF1R inhibition (A) Experimental paradigm depicting duration of PLX treatment and subsequent microglia gating and analysis. (B) PLX treatment increases the proportion of microglia expressing Galectin-3 to a greater extent in males compared to females. (C) PLX treatment increases the expression levels of Galectin-3 in Galectin-3+ microglia to a greater extent in males compared to females. (D–F) PLX treatment led to increased mitochondrial mass in female and male microglia, as estimated by expression of MitoTracker green. This effect was larger in males than in females (D). In both control and PLX groups, Galectin-3+ microglia appear to have a higher mitochondrial mass compared to Galectin-3 microglia in females (E) and males (F).

Article Snippet: After PLX treatment, CSF1R expression decreased in both Galectin-3+ and Galectin-3 microglia in both sexes (Figures 5H and 5I), and Galectin-3+ microglia had higher CSF1R expression than Galectin-3 microglia in males (Figure 5I), while expression normalized between the two populations in females (Figure 5H).

Techniques: Expressing, Inhibition, Control

FIGURE 9 | IL-21 rescued CD40L and anti-IgM induced cell death in human primary B cells. (A) Representative graphs of CFSE labelling cells showed no differentiation was induced by any stimulatory factors in 3 days. (B) Representative graphs showed that IL-21 could suppress cell death induced by CD40L and anti- IgM in terms of increased number of DAPI- cells. (C) Representative graphs showed that IL-21 was able to induce CD38+ B cell differentiation both in the absence and presence of CD40L.

Journal: Frontiers in immunology

Article Title: Interleukins 4 and 21 Protect Anti-IgM Induced Cell Death in Ramos B Cells: Implication for Autoimmune Diseases.

doi: 10.3389/fimmu.2022.919854

Figure Lengend Snippet: FIGURE 9 | IL-21 rescued CD40L and anti-IgM induced cell death in human primary B cells. (A) Representative graphs of CFSE labelling cells showed no differentiation was induced by any stimulatory factors in 3 days. (B) Representative graphs showed that IL-21 could suppress cell death induced by CD40L and anti- IgM in terms of increased number of DAPI- cells. (C) Representative graphs showed that IL-21 was able to induce CD38+ B cell differentiation both in the absence and presence of CD40L.

Article Snippet: Cells were then seeded into 96-well round bottom plate at the density of 2E5 cells/100μl, and then challenged with 50 ng/ml IL-21 and 1 μg/ml CD40L (#6420-CL/CF, R&D Systems, Minneapolis, USA) or 2 μg/ml anti-IgM.

Techniques: Cell Differentiation